News Minimalist logo

New malaria vaccines developed; R21 targets sporozoites, aids control

AllAfrica - Top Africa News — April 25, 2024, 09:00 AM UTC

Summary: Two malaria vaccines, RTS,S and R21, have been developed in the last three years. The R21/Matrix-M vaccine targets sporozoites to prevent malaria transmission. Children under five account for 80% of malaria deaths in Africa. The R21 vaccine, costing US$3.90 per dose, could significantly impact malaria control. With US$5 billion annually allocated to fight malaria, the goal is to reduce deaths to 200,000 by the end of the decade.

Full article

Article metrics
Significance5.0
Scale7.0
Magnitude7.5
Potential8.5
Novelty4.0
Actionability6.0
Immediacy8.0
Positivity9.0
Credibility7.5

Timeline:

  1. [5.2]
    African countries roll out malaria vaccine, new baby treatment (Health Policy Watch)
    19d
    Source
  2. [4.8]
    Benin, Liberia, Sierra Leone launch malaria vaccine programs in Africa (Voice of America - VOA News)
    23d
    Source
  3. [5.8]
    Malaria cases rose, Africa hit hardest, vaccines show promise (The Hindu)
    24d

    ScoresSource
  4. [6.6]
    New malaria vaccines R21 and RTS,S show promise (The Conversation)
    25d

    ScoresSource
  5. [6.7]
    Malaria vaccines show promise in Africa's fight against disease (The Conversation)
    27d

    ScoresSource